Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00

Published on 10/12/2026 at 09:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Chugai Pharmaceutical stock costs EUR 34.01 at Lang & Schwarz on October 12, 2026. Q3 results are due October 27, 2026 at 5:00 p.m. JST.

Key points in brief

Citi maintained a Buy rating on Chugai Pharmaceutical with a JPY 11,100.00 price target on October 7, 2026.
Chugai reported JPY 663.33 billion in revenue for the first half of fiscal 2026, up from JPY 578.46 billion.
The stock was trading at EUR 34.01 at Lang & Schwarz on October 12, 2026, at 9:15 a.m. CEST.
Chugai's fiscal 2026 third-quarter results are scheduled for October 27, 2026.

Chugai Pharmaceutical, JP3519400000, Illustration mit AI erstellt.

Chugai Pharmaceutical (ISIN JP3519400000) was trading at EUR 34.01 at Lang & Schwarz on October 12, 2026, at 9:15 a.m. CEST. Markets Insider reported on October 7, 2026, that Citi maintained a Buy rating and a JPY 11,100.00 price target for Chugai Pharmaceutical.

Revenue expands through June

Chugai reported JPY 663.33 billion in revenue for the first half of fiscal 2026, compared with JPY 578.46 billion in the same period a year earlier, according to the company's investor-relations materials. Net income reached JPY 231.75 billion, up from JPY 194.39 billion in the first half of fiscal 2025.

The June-quarter figures provide the latest operating reference: revenue was JPY 341.58 billion and net profit was JPY 116.33 billion, versus JPY 290.01 billion and JPY 97.16 billion a year earlier, respectively, according to Markets Insider.

Three dated milestones

For the fiscal year ended December 31, 2025, Chugai reported revenue of JPY 1.26 trillion, according to JPX Market Explorer. On July 24, 2026, the first-half revenue figure reached JPY 663.33 billion, while Citi's JPY 11,100.00 target dated October 7, 2026 became the latest quantified analyst signal.

What comes next for Chugai?

The company's investor-relations calendar lists fiscal 2026 third-quarter results for October 27, 2026, at 5:00 p.m. JST, followed by a results conference at 6:00 p.m. JST, according to Chugai Pharmaceutical. The next report will show whether the first-half revenue and profit comparison continued into the September quarter.

Stock trades at EUR 34.01

Chugai Pharmaceutical was trading at EUR 34.01 at Lang & Schwarz on October 12, 2026, at 9:15 a.m. CEST. Its primary listing is on the Tokyo Stock Exchange, where the company is identified as 4519.T and the October 9, 2026 close was JPY 6,019.00. The further course of trading is shown by the continuously updated real-time quote of Chugai Pharmaceutical stock.